Collectively, these studies in human samples, GEM models, and cancer cell lines demonstrate that histone methyltransferase ASH1L is genetically amplified and overexpressed in metastatic PCa, among other malignancies. The gene discussed is ASH1L; the disease is posterior cortical atrophy.